Detecting Micrometastatic Prostate Cancer Cells in Bone Marrow
Author Information
Author(s): T Deguchi, M Yang, H Ehara, S Ito, Y Nishino, Y Takahashi, Y Ito, K Shimokawa, T Tanaka, T Imaeda, T Doi, Y Kawada
Primary Institution: Gifu University School of Medicine
Hypothesis
Can reverse transcription-polymerase chain reaction (RT-PCR) detect micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer?
Conclusion
RT-PCR can detect micrometastatic prostate cancer cells in the bone marrow that are not visible through traditional bone scan imaging.
Supporting Evidence
- Of 35 patients, 14 had metastatic bone diseases including micrometastases.
- RT-PCR detected PSA mRNA in 7 of 26 patients with negative bone scans.
- Patients with a serum PSA concentration of 25 ng/ml or greater had a significantly higher risk of bone involvement.
Takeaway
Doctors can find tiny cancer cells in the bone marrow of prostate cancer patients using a special test, even when other tests say there are no cancer signs.
Methodology
The study used RT-PCR to analyze bone marrow samples from 35 prostate cancer patients to detect PSA mRNA expression.
Limitations
The study had a small sample size and insufficient information about the clinical significance of bone marrow micrometastases.
Participant Demographics
All participants were Japanese men with prostate cancer confirmed by histology.
Statistical Information
P-Value
p<0.01
Confidence Interval
71.3-100%
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website